• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一水合草酸钙和羟基磷灰石在乙二胺四乙酸(EDTA)溶液中的溶解度。

Solubility of calcium oxalate monohydrate and hydroxyapatite in EDTA solutions.

作者信息

Verplaetse H, Verbeeck R M, Verbaeys A, Oosterlinck W

出版信息

J Urol. 1986 Mar;135(3):608-11. doi: 10.1016/s0022-5347(17)45760-0.

DOI:10.1016/s0022-5347(17)45760-0
PMID:3003404
Abstract

The effect of the addition of a buffer to an ethylenediaminetetracetic acid (EDTA) litholytic solution on the solubility of calcium oxalate monohydrate and hydroxyapatite is investigated. The experiments show that the addition of triethanolamine as a buffer to EDTA solutions at pH 8 and 8.5 enhances the solubility of these salts, confirming theoretical predictions. The solubility of calcium oxalate monohydrate at 25C in solutions with varying ratios of buffer to EDTA concentrations and an osmolality of 0.9 was determined. The solutions resulting in the highest solubility were finally tested for their litholytic ability at 37C. At pH 8 solubilities of 22.5 g X l-1 for calcium oxalate monohydrate and 20.2 g X l-1 for hydroxyapatite were obtained. The corresponding solubilities at pH 8.5 were respectively 24.5 g X l-1 and 19.2 g X l-1.

摘要

研究了向乙二胺四乙酸(EDTA)溶石溶液中添加缓冲剂对一水合草酸钙和羟基磷灰石溶解度的影响。实验表明,在pH值为8和8.5的EDTA溶液中添加三乙醇胺作为缓冲剂可提高这些盐的溶解度,证实了理论预测。测定了25℃下,缓冲剂与EDTA浓度比例不同且重量克分子渗透压浓度为0.9的溶液中一水合草酸钙的溶解度。最终测试了溶解度最高的溶液在37℃时的溶石能力。在pH值为8时,一水合草酸钙的溶解度为22.5 g·L-1,羟基磷灰石的溶解度为20.2 g·L-1。在pH值为8.5时,相应的溶解度分别为24.5 g·L-1和19.2 g·L-1。

相似文献

1
Solubility of calcium oxalate monohydrate and hydroxyapatite in EDTA solutions.一水合草酸钙和羟基磷灰石在乙二胺四乙酸(EDTA)溶液中的溶解度。
J Urol. 1986 Mar;135(3):608-11. doi: 10.1016/s0022-5347(17)45760-0.
2
Solubility of inorganic kidney stone components in the presence of acid-base sensitive complexing agents.
Eur Urol. 1985;11(1):44-51. doi: 10.1159/000472448.
3
Epitaxial considerations in urinary stone formation. I. The urate-oxalate-phosphate system.尿路结石形成中的外延因素。I.尿酸盐 - 草酸盐 - 磷酸盐系统。
Invest Urol. 1980 Sep;18(2):178-84.
4
In vitro dissolution of calcium oxalate stones with ethylenediaminetetraacetic acid and snake venom thrombin-like enzyme.草酸钙结石在体外与乙二胺四乙酸和蛇毒类凝血酶的溶解情况
Urol Int. 2014;92(3):349-55. doi: 10.1159/000353096. Epub 2013 Nov 12.
5
Kinetics of dissolution of calcium oxalate calculi with calcium-chelating irrigating solutions.
J Urol. 1987 Mar;137(3):530-3. doi: 10.1016/s0022-5347(17)44100-0.
6
Screening of chelating agents for chemolysis.用于化学溶解的螯合剂筛选。
Eur Urol. 1986;12(3):190-4. doi: 10.1159/000472614.
7
Chemolysis of calcium containing urinary calculi. A review.含钙尿路结石的化学溶解疗法。综述。
Acta Urol Belg. 1994 Jun;62(2):31-7.
8
Epitaxial relationships in urolithiasis: the calcium oxalate monohydrate-hydroxyapatite system.
Clin Sci Mol Med. 1975 Nov;49(5):369-74. doi: 10.1042/cs0490369.
9
The influence of hydroxyapatite and pyrophosphate on the formation product of calcium oxalate at different pHs.
Urol Res. 1989;17(3):153-5. doi: 10.1007/BF00256242.
10
Nucleation kinetics in the calcium oxalate-sodium urate monohydrate system.草酸钙-尿酸钠一水合物体系中的成核动力学。
Invest Urol. 1981 Nov;19(3):197-201.

引用本文的文献

1
Therapeutic use of tetrasodium ethylenediaminetetraacetic acid solution for treatment of subcutaneous ureteral bypass device mineralization in cats.四钠乙二胺四乙酸溶液治疗猫皮下输尿管旁路装置矿化。
J Vet Intern Med. 2019 Sep;33(5):2124-2132. doi: 10.1111/jvim.15582. Epub 2019 Aug 6.
2
Urinary extracellular vesicles for RNA extraction: optimization of a protocol devoid of prokaryote contamination.尿液细胞外囊泡的 RNA 提取:优化无原核生物污染的方案。
J Extracell Vesicles. 2016 Jun 24;5:30281. doi: 10.3402/jev.v5.30281. eCollection 2016.
3
Toxicity of litholytic ethylenediaminetetraacetic acid solutions to the urothelium of the rat and dog.
Urol Res. 1991;19(4):265-8. doi: 10.1007/BF00305309.
4
Rationale for local toxicity of calcium chelators.
Urol Res. 1992;20(1):19-21. doi: 10.1007/BF00294329.